Brian Powl
Corporate Officer/Principal chez KURA ONCOLOGY, INC.
Fortune : 444 235 $ au 30/04/2024
Postes actifs de Brian Powl
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KURA ONCOLOGY, INC. | Corporate Officer/Principal | 14/08/2023 | - |
Historique de carrière de Brian Powl
Anciens postes connus de Brian Powl
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | - | - |
| FATE THERAPEUTICS, INC. | Corporate Officer/Principal | 30/06/2022 | - |
| MEI PHARMA, INC. | Sales & Marketing | 15/09/2020 | - |
Formation de Brian Powl
| University of California San Diego | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MEI PHARMA, INC. | Health Technology |
| FATE THERAPEUTICS, INC. | Health Technology |
| KURA ONCOLOGY, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Bourse
- Insiders
- Brian Powl
- Expérience